Daymark Wealth Partners LLC Has $1.19 Million Holdings in CVS Health Co. (NYSE:CVS)

Daymark Wealth Partners LLC decreased its position in CVS Health Co. (NYSE:CVS) by 70.7% during the 4th quarter, Holdings Channel.com reports. The firm owned 26,537 shares of the pharmacy operator’s stock after selling 64,160 shares during the period. Daymark Wealth Partners LLC’s holdings in CVS Health were worth $1,191,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. MidAtlantic Capital Management Inc. acquired a new stake in shares of CVS Health during the third quarter worth $25,000. Livelsberger Financial Advisory acquired a new stake in CVS Health in the 3rd quarter worth about $31,000. Legacy Investment Solutions LLC acquired a new position in shares of CVS Health during the 3rd quarter worth approximately $31,000. Reston Wealth Management LLC bought a new position in shares of CVS Health during the third quarter worth approximately $32,000. Finally, Kathleen S. Wright Associates Inc. bought a new stake in shares of CVS Health in the third quarter valued at approximately $33,000. 80.66% of the stock is currently owned by institutional investors.

CVS Health Trading Down 0.2 %

CVS opened at $53.05 on Thursday. CVS Health Co. has a twelve month low of $43.56 and a twelve month high of $80.75. The company has a fifty day moving average of $51.26 and a 200-day moving average of $56.26. The stock has a market cap of $66.76 billion, a PE ratio of 13.46, a price-to-earnings-growth ratio of 0.80 and a beta of 0.59. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping the consensus estimate of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The firm had revenue of $95.43 billion during the quarter, compared to analyst estimates of $92.72 billion. During the same period last year, the company posted $2.21 EPS. The business’s quarterly revenue was up 6.3% on a year-over-year basis. On average, sell-side analysts predict that CVS Health Co. will post 5.22 EPS for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd will be paid a $0.665 dividend. The ex-dividend date is Thursday, January 23rd. This represents a $2.66 annualized dividend and a dividend yield of 5.01%. CVS Health’s dividend payout ratio is currently 67.51%.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the company. Evercore ISI raised their price target on CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 8th. Barclays cut their price target on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a report on Thursday, November 7th. UBS Group upped their target price on CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a research note on Thursday, November 7th. Royal Bank of Canada decreased their price target on CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a research note on Friday, November 15th. Finally, Deutsche Bank Aktiengesellschaft raised CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price objective on the stock in a research note on Tuesday, December 3rd. One research analyst has rated the stock with a sell rating, six have issued a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $68.71.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.